EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases

Quentin Delbaere iD, Nicolas Chapet, Fabien Huet iD, Clément Delmas iD, Nathan Mewton, Fabrice Prunier, Denis Angoulvant iD, François Roubille iD

Pharmaceuticals · 04.01.2023 · 16 (1) · 78

DOI: 10.3390/ph16010078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 04.01.2023. Verfasst von Quentin Delbaere und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Arnaud de Villeneuve University Hospital, 34295 Montpellier, France. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Incidence and mortality rates for cardiovascular disease are declining, but it still remains a major cause of morbidity and mortality. Drug treatments to slow the progression of atherosclerosis focus on reducing cholesterol levels. The paradigm shift to consider atherosclerosis an inflammatory disease by itself has led to the development of new treatments. In this article, we discuss the pathophysiology of inflammation and focus attention on therapeutics targeting different inflammatory pathways of atherosclerosis and myocardial infarction. In atherosclerosis, colchicine is included in new recommendations, and eight randomized clinical trials are testing new drugs in different inflammatory pathways. After a myocardial infarction, no drug has shown a significant benefit, but we present four randomized clinical trials with new treatments targeting inflammation.

Schlagwörter

Stichwörter der Autor:innen

anti-inflammatoryatherosclerosisdrugsmyocardial infarction

Autor:innen und Institutionen

  • Department of Cardiology, Arnaud de Villeneuve University Hospital, 34295 Montpellier, France.
  • Department of Cardiology, Bretagne Atlantique General Hospital, 56000 Vannes, France.
  • Hôpital Cardiovasculaire Louis Pradel, 69002 Lyon, France.
  • Department of Cardiology, CHU Angers, Université d'Angers, 49100 Angers, France.
  • Cardiology Department, CHRU de Tours, 37044 Tours, France.
  • EA 4245 T2I, Université de Tours, 37044 Tours, France.

ORCID-Profile: Quentin Delbaere, Fabien Huet, Clément Delmas, Denis Angoulvant, François Roubille

Zitieren

APA

Delbaere, Q., Chapet, N., Huet, F., Delmas, C., Mewton, N., Prunier, F., Angoulvant, D., & Roubille, F. (2023). Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases. Pharmaceuticals, 16(1), 78. https://doi.org/10.3390/ph16010078

Vancouver

Delbaere Q, Chapet N, Huet F, Delmas C, Mewton N, Prunier F, et al. Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases. Pharmaceuticals. 2023;16(1):78. doi:10.3390/ph16010078

BibTeX
@article{Delbaere2023,
  author = {Delbaere, Quentin and Chapet, Nicolas and Huet, Fabien and Delmas, Clément and Mewton, Nathan and Prunier, Fabrice and Angoulvant, Denis and Roubille, François},
  title = {Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {1},
  pages = {78},
  doi = {10.3390/ph16010078}
}
Kostenlos starten →